Christopher C. Thompson, MD, MSc
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Christopher C. Thompson, MD, MSc sits in the upper quartile of US sponsors by registered trial count (#2,411 of 15,742 sponsors by registered trial count).
Christopher C. Thompson, MD, MSc: 5 sponsored US clinical trials, 5 recruiting.
Christopher C. Thompson, MD, MSc sponsors 5 registered US clinical trials on ClinicalTrials.gov, 5 of them currently recruiting. The most-studied condition in this pipeline is Obesity, Morbid, with 2 trials.
Upper-quartile sponsor footprint
Christopher C. Thompson, MD, MSc sits in the upper quartile of the sponsor corpus (#2,411 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
5 total, page 1 of 1
Trans-nasal Endoscopy for Bariatric Patients
NCT06200961
Necrosectomy With Cryotechnology for Accelerated Removal
NCT06553651
H. Pylori Eradication With Argon Plasma During Endoscopy
NCT06529159
Marginal Ulcer Healing With Low-Thermal Argon Plasma Endoscopic Treatment
NCT06543316
Efficacy and Safety of Endoscopic Antral Myotomy as a Novel Weight Loss Procedure
NCT05711758
What is open in the Christopher C. Thompson, MD, MSc pipeline
5 recruiting of 5 indexed (100% open).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Obesity, Morbid (2 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Christopher C. Thompson, MD, MSc: open-pipeline peers nationwide
Peers matched on 5 registered trials and 100% open enrollment, not the therapeutic-area sidebar.
Christopher C. Thompson, MD, MSc sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 5 trials (± recruiting share)
- 4YouandMe · 5 trials · 0% recruiting
- Abbott Rapid Dx · 5 trials · 0% recruiting
- Access Business Group · 5 trials · 0% recruiting
- Acera Surgical · 5 trials · 20% recruiting
Sponsors near 100% open enrollment (± trial volume)
- AAVantgarde Bio Srl · 100% recruiting · 2 trials
- Acorn Biolabs · 100% recruiting · 3 trials
- Acrivon Therapeutics · 100% recruiting · 2 trials
- ADARx Pharmaceuticals · 100% recruiting · 4 trials
Related
What to do with this Christopher C. Thompson, MD, MSc page
5 registered trials is a research-attention snapshot, not an endorsement of Christopher C. Thompson, MD, MSc or any single study.
- 5 of Christopher C. Thompson, MD, MSc's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity, Morbid is the condition Christopher C. Thompson, MD, MSc studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity, Morbid trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Christopher C. Thompson, MD, MSc pipeline card: 5 registered trials from official public datasets.Report a data error.